These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins. Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740 [TBL] [Abstract][Full Text] [Related]
5. Mathematical modelling of CRISPR-Cas system effects on biofilm formation. Ali Q; Wahl LM J Biol Dyn; 2017 Aug; 11(sup2):264-284. PubMed ID: 28426329 [TBL] [Abstract][Full Text] [Related]
6. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition. Bradde S; Mora T; Walczak AM Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281 [TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas: Spacer Diversity Determines the Efficiency of Defense. Lopatina A; Sorek R Curr Biol; 2016 Jul; 26(14):R683-5. PubMed ID: 27458917 [TBL] [Abstract][Full Text] [Related]
8. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system]. Tan JJ; Peng YZ; Huang GT Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411 [TBL] [Abstract][Full Text] [Related]
9. [CRISPR/Cas systems in genome engineering of bacteriophages]. Liang CJ; Meng FM; Ai YC Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946 [TBL] [Abstract][Full Text] [Related]
10. Programming Native CRISPR Arrays for the Generation of Targeted Immunity. Hynes AP; Labrie SJ; Moineau S mBio; 2016 May; 7(3):. PubMed ID: 27143383 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of CRISPR-mediated microbial immunity. Gasiunas G; Sinkunas T; Siksnys V Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171 [TBL] [Abstract][Full Text] [Related]
13. CRISPR recognizes as many phage types as possible without overwhelming the Cas machinery. Deem MW Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7550-7552. PubMed ID: 32209669 [No Abstract] [Full Text] [Related]
15. New CRISPR-Cas systems discovered. Yang H; Patel DJ Cell Res; 2017 Mar; 27(3):313-314. PubMed ID: 28220773 [TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens. Marraffini LA PLoS Pathog; 2013; 9(12):e1003765. PubMed ID: 24348245 [No Abstract] [Full Text] [Related]
17. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes. Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV mBio; 2017 Sep; 8(5):. PubMed ID: 28928211 [TBL] [Abstract][Full Text] [Related]
18. Structural basis of CRISPR-Cas Type III prokaryotic defence systems. Molina R; Sofos N; Montoya G Curr Opin Struct Biol; 2020 Dec; 65():119-129. PubMed ID: 32712502 [TBL] [Abstract][Full Text] [Related]
19. CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers. Pourcel C; Touchon M; Villeriot N; Vernadet JP; Couvin D; Toffano-Nioche C; Vergnaud G Nucleic Acids Res; 2020 Jan; 48(D1):D535-D544. PubMed ID: 31624845 [TBL] [Abstract][Full Text] [Related]
20. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. van der Oost J; Westra ER; Jackson RN; Wiedenheft B Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]